NasdaqGS - Delayed Quote USD

GE HealthCare Technologies Inc. (GEHC)

76.34 -0.66 (-0.86%)
At close: June 7 at 4:00 PM EDT
76.20 -0.14 (-0.18%)
After hours: June 7 at 7:48 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
19,495,000.00
19,552,000.00
18,341,000.00
17,585,000.00
17,164,000.00
--
Cost of Revenue
11,563,000.00
11,630,000.00
11,162,000.00
10,411,000.00
10,397,000.00
--
Gross Profit
7,933,000.00
7,922,000.00
7,179,000.00
7,174,000.00
6,767,000.00
--
Operating Expense
5,517,000.00
5,487,000.00
4,657,000.00
4,379,000.00
4,047,000.00
--
Operating Income
2,416,000.00
2,435,000.00
2,522,000.00
2,795,000.00
2,720,000.00
--
Net Non Operating Interest Income Expense
-531,000.00
-516,000.00
-86,000.00
-6,000.00
-17,000.00
--
Other Income Expense
441,000.00
442,000.00
76,000.00
86,000.00
7,000.00
--
Pretax Income
2,327,000.00
2,361,000.00
2,512,000.00
2,875,000.00
2,710,000.00
--
Tax Provision
704,000.00
743,000.00
563,000.00
600,000.00
652,000.00
--
Net Income Common Stockholders
1,570,000.00
1,385,000.00
1,916,000.00
2,247,000.00
13,846,000.00
--
Diluted NI Available to Com Stockholders
1,570,000.00
1,385,000.00
1,916,000.00
2,247,000.00
13,846,000.00
--
Basic EPS
3.45
3.05
4.63
4.94
30.45
--
Diluted EPS
3.43
3.03
4.63
4.94
30.45
--
Basic Average Shares
455,500.00
455,000.00
413,822.89
454,710.00
454,710.00
--
Diluted Average Shares
458,500.00
458,000.00
413,822.89
454,710.00
454,710.00
--
Total Operating Income as Reported
2,416,000.00
2,435,000.00
2,522,000.00
2,795,000.00
2,720,000.00
--
Total Expenses
17,080,000.00
17,117,000.00
15,819,000.00
14,790,000.00
14,444,000.00
--
Net Income from Continuing & Discontinued Operation
1,570,000.00
1,568,000.00
1,916,000.00
2,247,000.00
13,846,000.00
--
Normalized Income
1,574,000.00
1,572,000.00
1,898,000.00
2,229,000.00
2,007,000.00
--
Interest Income
--
26,000.00
--
34,000.00
49,000.00
36,000.00
Interest Expense
544,000.00
542,000.00
86,000.00
40,000.00
66,000.00
--
Net Interest Income
-531,000.00
-516,000.00
-86,000.00
-6,000.00
-17,000.00
--
EBIT
2,871,000.00
2,903,000.00
2,598,000.00
2,915,000.00
2,776,000.00
--
EBITDA
3,472,000.00
3,513,000.00
3,231,000.00
3,540,000.00
3,406,000.00
--
Reconciled Cost of Revenue
11,563,000.00
11,630,000.00
11,162,000.00
10,411,000.00
10,397,000.00
--
Reconciled Depreciation
601,000.00
610,000.00
633,000.00
625,000.00
630,000.00
--
Net Income from Continuing Operation Net Minority Interest
1,574,000.00
1,572,000.00
1,898,000.00
2,229,000.00
2,007,000.00
--
Normalized EBITDA
3,472,000.00
3,513,000.00
3,231,000.00
3,540,000.00
3,406,000.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
12/31/2019 - 12/15/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SOLV Solventum Corporation
56.41
+2.47%
 
VEEV Veeva Systems Inc.
183.14
-1.01%
 
TDOC Teladoc Health, Inc.
10.64
-3.54%
 
HQY HealthEquity, Inc.
85.25
+1.86%
 
GDRX GoodRx Holdings, Inc.
8.55
-2.73%
 
SDGR Schrödinger, Inc.
21.74
-7.09%
 
DOCS Doximity, Inc.
29.47
+0.92%
 
TXG 10x Genomics, Inc.
21.87
-2.93%
 
WAY Waystar Holding Corp. Common Stock
20.70
-3.72%
 
PGNY Progyny, Inc.
27.60
-1.18%